EFFECT OF MONTELUKAST ON CAPSULAR CONTRACTURE AFTER BREAST AUGMENTATION: A COMPARATIVE STUDY

Salvatore Giordano, FINLAND
BACKGROUND: Leukotriene antagonists zafirlukast and montelukast have been used by plastic surgeons off-label to prevent and treat capsular contracture in breast implant surgery. At the present, only few studies investigated their efficacy.
METHODS:
A retrospective analysis was performed to investigate the effectiveness of montelukast in preventing and treating capsular contracture.
This study included 177 consecutive women who underwent cosmetic breast surgery using textured silicone prostheses.
Same surgeon operated all women using inframammary approach and dual-plane pocket and a treatment of at least 3 months of montelukast was offered to them at the regimen of 20mg once a day. Therefore, patients were divided into two groups on the basis of montelukast treatment.
Follow-up on montelukast efficacy was obtained by a combination of office chart review and strandardized telephone questionnaire with a minimum follow-up of 4 years.
RESULTS:
Sixty-seven patients received montelukast for 3-6 months. Mean age of the patients was 35.82 ± 8.71 years (range 19-56 years), and co-morbidity was present in 11.76% of cases. All groups combined had a mean follow-up evaluation of 58.71 ± 13.45 months (range 48-136 months) and mean breast size (cc) of 333.89 ± 107.60 cc (range 155-690 cc).
No significant differences were found for the use of montelukast versus control in the prevention of capsular contracture after surgery, although the number of affected patients and the severity of capsular contracture were higher among the patients who did not use montelukast. No adverse effects were found.
CONCLUSIONS:
Montelukast may prevent and improve symptoms of capsular contracture. However, further studies are needed for justifying its somministration.
REGENERATIVE PLASTIC SURGERY IN POSTMASTECTOMY BREAST RECONSTRUCTION -EVOLUTION OF THE CONCEPT REFLECTED IN CURRENT PERSONAL PRACTICE
Dana Jianu, Oltjon Cobani, Ioana Ghiurco, Marian Turbatu, Mihaela Vartic, ROMANIA BACKGROUND: The concept to restore the breast postmastectomy through regenerative surgery with fat tissue and implants or to regenerate it solely with fat tissue and reverse expansion (RE) is not new but still a rare procedure.
Friday, August 25, 2017
Abstracts EPSRC In this respect, we learned and we'd like to share our experience to obtain predictable and pleasant results -due to a better understanding of the concept and new methodology.
MATERIAL AND METHOD:
Since 2003, the team of the Department of Plastic Surgery of ProEstetica Hospital has been started the composite regenerative breast surgery with fat graft, internal expansion and silicone prosthesis -15 cases. From November 2010 till June 2017 were performed other 20 cases of regenerative reconstructions after mastectomy based on RE expansion (four cases combination). As a consequence, this paper is presenting a comparative study between the two methods of breast reconstruction with and without RE.
All stages with reverse expansion surgical technique and imagistic follow-up are summarized.
RESULTS:
The results are presented by stages, commented with concision about difficulties and challenges encountered. A series of pictures of cases is shown.
CONCLUSION: 1. The regenerative breast surgery (RBS) reconstruction and aesthetics is a more gentle yet efficient method when compared with distant flaps. 2. The RE is ensuring optimal conditions for a better fat survival even in the very scarce vascularisation post radiotherapy. On the contrary, the absence of the RE could lead to the failure of surgical augmentation. Despite multiple advantages, the regenerative surgery of the breast is currently less popular and less accepted by our plastic and oncologic colleagues or from other specialties. 3. The limits and advantages of RBS are also presented.
